Literature DB >> 33778671

q-Space Imaging Yields a Higher Effect Gradient to Assess Cellularity than Conventional Diffusion-weighted Imaging Methods at 3.0 T: A Pilot Study with Freshly Excised Whole-Breast Tumors.

Nicholas Senn1, Yazan Masannat1, Ehab Husain1, Bernard Siow1, Steven D Heys1, Jiabao He1.   

Abstract

Purpose: To determine whether q-space imaging (QSI), an advanced diffusion-weighted MRI method, provides a higher effect gradient to assess tumor cellularity than existing diffusion imaging methods, and fidelity to cellularity obtained from histologic analysis. Materials and
Methods: In this prospective study, diffusion-weighted images were acquired from 20 whole-breast tumors freshly excised from participants (age range, 35-78 years) by using a clinical 3.0-T MRI unit. Median and skewness values were extracted from the histogram distributions obtained from QSI, monoexponential model, diffusion kurtosis imaging (DKI), and stretched exponential model (SEM). The skewness from QSI and other diffusion models was compared by using paired t tests and relative effect gradient obtained from correlating skewness values.
Results: The skewness obtained from QSI (mean, 1.34 ± 0.77 [standard deviation]) was significantly higher than the skewness from monoexponential fitting approach (mean, 1.09 ± 0.67; P = .015), SEM (mean, 1.07 ± 0.70; P = .014), and DKI (mean, 0.97 ± 0.63; P = .004). QSI yielded a higher effect gradient in skewness (percentage increase) compared with monoexponential fitting approach (0.26 of 0.74; 35.1%), SEM (0.26 of 0.74; 35.1%), and DKI (0.37 of 0.63; 58.7%). The skewness and median from QSI were significantly correlated with the skewness (ρ = -0.468; P = .038) and median (ρ = -0.513; P = .021) of cellularity from histologic analysis.
Conclusion: QSI yields a higher effect gradient in assessing breast tumor cellularity than existing diffusion methods, and fidelity to underlying histologic structure.Keywords: Breast, MR-Diffusion Weighted Imaging, MR-Imaging, Pathology, Tissue Characterization, Tumor ResponseOnline supplemental material is available for this article.Published under a CC BY 4.0 license. 2019 by the Radiological Society of North America, Inc.

Entities:  

Year:  2019        PMID: 33778671      PMCID: PMC7983771          DOI: 10.1148/rycan.2019190008

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN: 2638-616X


  39 in total

1.  Reassessment of the rate of fixative diffusion.

Authors:  R D Start; C M Layton; S S Cross; J H Smith
Journal:  J Clin Pathol       Date:  1992-12       Impact factor: 3.411

2.  Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors.

Authors:  Kun Sun; Xiaosong Chen; Weimin Chai; Xiaochun Fei; Caixia Fu; Xu Yan; Ying Zhan; Kemin Chen; Kunwei Shen; Fuhua Yan
Journal:  Radiology       Date:  2015-05-04       Impact factor: 11.105

3.  Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.

Authors:  Florentia Peintinger; Bruno Sinn; Christos Hatzis; Constance Albarracin; Erinn Downs-Kelly; Jerzy Morkowski; Rebekah Gould; W Fraser Symmans
Journal:  Mod Pathol       Date:  2015-05-01       Impact factor: 7.842

4.  Diffusion tensor imaging of breast lesions: evaluation of apparent diffusion coefficient and fractional anisotropy and tissue cellularity.

Authors:  Ruisheng Jiang; Zhijun Ma; Haixia Dong; Shihang Sun; Xiangmin Zeng; Xiao Li
Journal:  Br J Radiol       Date:  2016-06-15       Impact factor: 3.039

5.  Diffusion-weighted imaging of breast lesions: Region-of-interest placement and different ADC parameters influence apparent diffusion coefficient values.

Authors:  Hubert Bickel; Katja Pinker; Stephan Polanec; Heinrich Magometschnigg; Georg Wengert; Claudio Spick; Wolfgang Bogner; Zsuzsanna Bago-Horvath; Thomas H Helbich; Pascal Baltzer
Journal:  Eur Radiol       Date:  2016-08-30       Impact factor: 5.315

6.  Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response.

Authors:  Ann D King; Kwok-Keung Chow; Kwok-Hung Yu; Frankie Kwok Fai Mo; David K W Yeung; Jing Yuan; Kunwar S Bhatia; Alexander C Vlantis; Anil T Ahuja
Journal:  Radiology       Date:  2012-11-14       Impact factor: 11.105

7.  Pathologic response and long-term follow-up in breast cancer patients treated with neoadjuvant chemotherapy: a comparison between classifications and their practical application.

Authors:  Adriana D Corben; Rita Abi-Raad; Ion Popa; Clarence H Y Teo; Eric A Macklin; Frederick C Koerner; Alphonse G Taghian; Elena F Brachtel
Journal:  Arch Pathol Lab Med       Date:  2013-08       Impact factor: 5.534

8.  Esophageal carcinoma: Evaluation with q-space diffusion-weighted MR imaging ex vivo.

Authors:  Ichiro Yamada; Keigo Hikishima; Naoyuki Miyasaka; Yutaka Tokairin; Eisaku Ito; Tatsuyuki Kawano; Daisuke Kobayashi; Yoshinobu Eishi; Hideyuki Okano
Journal:  Magn Reson Med       Date:  2014-06-19       Impact factor: 4.668

9.  Microstructural models for diffusion MRI in breast cancer and surrounding stroma: an ex vivo study.

Authors:  Colleen Bailey; Bernard Siow; Eleftheria Panagiotaki; John H Hipwell; Thomy Mertzanidou; Julie Owen; Patrycja Gazinska; Sarah E Pinder; Daniel C Alexander; David J Hawkes
Journal:  NMR Biomed       Date:  2016-12-21       Impact factor: 4.044

10.  Intravoxel incoherent motion (IVIM) histogram biomarkers for prediction of neoadjuvant treatment response in breast cancer patients.

Authors:  Gene Y Cho; Lucas Gennaro; Elizabeth J Sutton; Emily C Zabor; Zhigang Zhang; Dilip Giri; Linda Moy; Daniel K Sodickson; Elizabeth A Morris; Eric E Sigmund; Sunitha B Thakur
Journal:  Eur J Radiol Open       Date:  2017-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.